FDA
-
-
-
-
-
-
-
Longboard Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2021 Financial Results
-
-
-
-
-
-
-
Arena Pharmaceuticals Announces First Participant Randomized in Phase 2 Trial Evaluating Temanogrel in Coronary Microvascular Obstruction (cMVO)
-
-
-
-
-
-
-
Arena Pharmaceuticals Achieves Target Enrollment for Etrasimod Phase 3 ELEVATE UC 52 Trial
-
-
-
-
-
-
-
Arena Pharma (ARNA) Announces R&D Leadership Transition
-
-
-
-
-
-
-
FDA Grants Fast Track Designation to Arena Pharmaceuticals' APD418 for Development in Decompensated Heart Failure Patients
-
-
-
-
-
-
-
Pre-Open Movers 09/25: (ASNA) (TLRY) (NIHD) Higher; (TGTX) (OPNT) (SNDX) Lower (more...)
-
-
-
-
-
-
-
Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2017 Financial Results
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

